{"id":"tp-31698","type":"article-newspaper","title":"Verastem Oncology Names Michael Bailey as CEO, Prices $250 Million Offering","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/31698","datePublished":"2026-10-14T10:17:24.000Z","dateModified":"2026-10-14T10:17:24.000Z","language":"en","abstract":"Shares climbed around 20% in premarket trading Wednesday, Oct. 14. Bailey’s appointment takes effect Jan. 1, 2027.","section":"Business","references":[]}